Business · 10/06/1998Updated: 10/17/2026 · 1 min read
FDA Approves New Animal Drug for Treatment of Small Strongyle Larvae
Summary
The US Food and Drug Administration (FDA) has amended its regulations to reflect the approval of a supplemental new animal drug application (NADA) filed by Hoechst Roussel Vet, expanding the indications for the treatment of encysted mucosal cyathostome (small strongyle) larvae in horses.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →